Primary Record
FORMOTEROL FUMARATE
- In stock
- 5,783 g
- Purity
- 98.5 %
- CAS
- 43229-80-7
Compound Identifiers & Properties
- CAS
- 43229-80-7
- PubChem CID
- 53477580
- SMILES
- C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O.C(=C/C(=O)O)\C(=O)O
- Canonical SMILES
- COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1.O=C(O)/C=C/C(=O)O
Names & Synonyms
- FORMOTEROL FUMARATE
- Atock
- Perforomist
- Foradil
- aformoterol
- Performist
- Foradil Certihaler
- Formoterol hemifumarate
- Foradil acrolizer
- Foraseq
- Foradil Aerolizer
- Oxeze
- Atimos modulite
- Fomoterol fumarate
- Oxis
- Oxis pMDi
- Eformoterol;
- FORMOTEROLFUMARATE
- Formoterol (Fumarate)
- arformoterol fumarate
- 43229-80-7
- Oxis 6
- Oxis 12
- P3T5QA5J9N
- Formoterol (Fumarate)?
- RefChem:56497
- UNII-P3T5QA5J9N
- BD 40A
- Formoterol fumarate anhydrous
- Formoterol fumarate dihydrate
- Formoterol fumarate (superceded)
- (R,R)-formoterol fumarate
- Formoterol fumarate [USAN]
- CGP 25827A
- W34SHF8J2K
- DTXSID5044239
- BD-40A
- SCHEMBL3040814
- CHEMBL3184383
- FORMOTEROL FUMARATE [MI]
- CHEBI:31633
- CHEBI:63108
- DTXCID40196618
- Formoterol fumarate inhalation powder
- Formoterol fumarate [USAN:USP:JAN]
- MFCD03093863
- CGP-25827A
- YM 08316
- YM-08316
- NSC 299587
- NSC-299587
- C42H52N4O12
- HY-B0010
- Tox21_112734
- Formoterol fumarate (superceded) [USAN]
- FORMOTEROL FUMARATE [WHO-DD]
- MFCD11045919
- NSC299587
- Formoterol for system suitability CRS
- AKOS027427027
- CS-1326
- Formoterol, ((R*,R*)-(+-))-
- Formoterol for impurity I identification
- NCGC00181126-01
- C19H24N2O4.1/2C4H4O4
- Formoterol fumarate for system suitability
- Formoterol fumarate, 97% - 10MG 10mg
- AB0072702
- BREZTRI COMPONENT FORMOTEROL FUMARATE
- CAS-43229-80-7
- Formoterol Fumarate, ((R*,R*)-(+-))-
- Formoterol for impurity I identification CRS
- NS00076334
- A826230
- C19-H24-N2-O4.1/2C4-H4-O4
- Formoterol for system suitability CRS (Y0002298)
- Q27132391
- SYMBICORT COMPONENT FORMOTEROL FUMARATE DIHYDRATE
- Formoterol for impurity I identification CRS (Y0000339)
- Formoterol Fumarate Inhalation Solution and PARI LC PLUS Nebulizer
- N-(2-hydroxy-5-((R)-1-hydroxy-2-(((R)-1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenyl)formamide hemifumarate
- (+-)-2'-Hydroxy-5'-((R*)-1-hydroxy-2-(((R*)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide fumarate (2:1) (salt)
- (+/-)-2'-HYDROXY-5'-((R*)-1-HYDROXY-2-(((R*)-P-METHOXY-.ALPHA.-METHYLPHENETHYL)AMINO)ETHYL)FORMANILIDE FUMARATE (2:1) (SALT)
- (2E)-But-2-enedioic acid--N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide (1/2)
- (E)-but-2-enedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
- (E)-but-2-enedioic acid;N-[2-hydroxy-5-[(1S)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide
- 183814-30-4
- 3-formylamino-4-hydroxy-alpha-(N-1-methyl-2-p-methoxyphenethylaminomethyl)benzyl alcohol.hemifumarate
- 87833-61-2
- bis[(2R)-N-{(2R)-2-[3-(formylamino)-4-hydroxyphenyl]-2-hydroxyethyl}-1-(4-methoxyphenyl)propan-2-aminium] (2E)-but-2-enedioate
- Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, rel-, (E)-2-butenedioate (2:1) (salt)
- Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, rel-,(E)-2-butenedioate(2:1)(salt)
- Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, rel-, (2E)-2-butenedioate (2:1) (salt)
- fumaric acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]formamide
- N-(2-Hydroxy-5-(1-hydroxy-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide, (E)-2-butenedioate (2:1) (salt)
- N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide (2E)-but-2-enedioate